J&J Covid-19 Booster Shot under discussion by FDA Advisers

recent studies have proven that the effectiveness of Covid-19 vaccines is decreasing, notwithstanding specialists say the pictures nevertheless work neatly. WSJ explains what the numbers suggest and why they don't tell the whole story. photo illustration: Jacob Reynolds/WSJ

Advisers to the meals and Drug Administration voted unanimously Friday to suggest the agency authorize a further dose of Johnson & Johnson 's Covid-19 vaccine, to shore up insurance policy against the coronavirus.

The panel of outdoor medical doctors and consultants voted 19-0 to advocate that each one adults who bought a primary dose of the J&J vaccine may still get the 2d dose at the least two months later.